Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation
The human voltage gated potassium channel Kv1.5 that conducts the I<sub>Kur</sub> current is a key determinant of the atrial action potential. Its mutations have been linked to hereditary forms of atrial fibrillation (AF), and the channel is an attractive target for the management of AF....
Saved in:
Main Authors: | Jesús Borrego (Author), Adam Feher (Author), Norbert Jost (Author), Gyorgy Panyi (Author), Zoltan Varga (Author), Ferenc Papp (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Novel Insecticidal Spider Peptide that Affects the Mammalian Voltage-Gated Ion Channel hKv1.5
by: Diana Alvarado, et al.
Published: (2021) -
New Strategies for the Treatment of Atrial Fibrillation
by: Norbert Jost, et al.
Published: (2021) -
5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human H<sub>V</sub>1 Channel
by: Tibor G. Szanto, et al.
Published: (2023) -
Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option
by: Manuel Kraft, et al.
Published: (2021) -
The Properties of the Transient Outward, Inward Rectifier and Acetylcholine-Sensitive Potassium Currents in Atrial Myocytes from Dogs in Sinus Rhythm and Experimentally Induced Atrial Fibrillation Dog Models
by: Zsófia Kohajda, et al.
Published: (2024)